CDB25:0004012 NRXN1 — LRRTM2

Experimentally validated in Mixed species, Mouse; Orthology-inferred in Human, Mouse, Rat, Frog, Zebrafish, Chicken, Macaque, Pig, Dog, Cow, Chimp, Horse, Marmoset, Sheep

Title

Journal:; Year Published:

Abstract

LRRTM2 functions as a neurexin ligand in promoting excitatory synapse formation.

Neuron, 2009; PubMed, Bos taurus NRXN1 — Mus Musculus Lrrtm2
ABSTRACT: Recently, leucine-rich repeat transmembrane proteins (LRRTMs) were found to be synaptic cell-adhesion molecules that, when expressed in nonneuronal cells, induce presynaptic differentiation in contacting axons. We now demonstrate that LRRTM2 induces only excitatory synapses, and that it also acts to induce synapses in transfected neurons similarly to neuroligin-1. Using affinity chromatography, we identified alpha- and beta-neurexins as LRRTM2 ligands, again rendering LRRTM2 similar to neuroligin-1. However, whereas neuroligins bind neurexins containing or lacking an insert in splice site #4, LRRTM2 only binds neurexins lacking an insert in splice site #4. Binding of neurexins to LRRTM2 can produce cell-adhesion junctions, consistent with a trans-interaction regulated by neurexin alternative splicing, and recombinant neurexin-1beta blocks LRRTM2's ability to promote presynaptic differentiation. Thus, our data suggest that two unrelated postsynaptic cell-adhesion molecules, LRRTMs and neuroligins, unexpectedly bind to neurexins as the same presynaptic receptor, but that their binding is subject to distinct regulatory mechanisms.

LRRTM2 controls presynapse nano-organization and AMPA receptor sub-positioning through Neurexin-binding interface.

Nature communications, 2024; PubMed, Mus Musculus Nrxn1 — Mus Musculus Lrrtm2
ABSTRACT: Synapses are organized into nanocolumns that control synaptic transmission efficacy through precise alignment of postsynaptic neurotransmitter receptors and presynaptic release sites. Recent evidence show that Leucine-Rich Repeat Transmembrane protein LRRTM2, highly enriched and confined at synapses, interacts with Neurexins through its C-terminal cap, but the role of this binding interface has not been explored in synapse formation and function. Here, we develop a conditional knock-out mouse model (cKO) to address the molecular mechanisms of LRRTM2 regulation, and its role in synapse organization and function. We show that LRRTM2 cKO specifically impairs excitatory synapse formation and function in mice. Surface expression, synaptic clustering, and membrane dynamics of LRRTM2 are tightly controlled by selective motifs in the C-terminal domain. Conversely, the N-terminal domain controls presynapse nano-organization and postsynapse AMPAR sub-positioning and stabilization through the recently identified Neurexin-binding interface. Thus, we identify LRRTM2 as a central organizer of pre- and post- excitatory synapse nanostructure through interaction with presynaptic Neurexins.
Basic Information on NRXN1
Ligand Name: neurexin 1
Other Symbols: KIAA0578, Hs.22998
Ligand Location: cell membrane based on hpa, perplexity, uniprot
HGNC Gene Symbol Report: NRXN1
GeneCards: NRXN1
HGNC Gene Group: Neurexins, MicroRNA host genes
Basic Information on LRRTM2
Receptor Name: leucine rich repeat transmembrane neuronal 2
Other Symbols: KIAA0416
Receptor Location: cell membrane based on perplexity, uniprot
HGNC Gene Symbol Report: LRRTM2
GeneCards: LRRTM2
HGNC Gene Group: unknown
Interactions with other Ligands for LRRTM2